Article
The mTORC1 Inhibitor Everolimus Prevents and Treats Eμ- <i>Myc</i> Lymphoma by Restoring Oncogene-Induced Senescence
15 Dec 2012
Abstract excerpt
UNLABELLED: MYC deregulation is common in human cancer. IG-MYC translocations that are modeled in Eμ-Myc mice occur in almost all cases of Burkitt lymphoma as well as in other B-cell lymphoproliferative disorders. Deregulated expression of MYC results in increased mTOR complex 1 (mTORC1) signaling. As tumors with mTORC1 activation are sensitive to mTORC1 inhibition, we used everolimus, a potent and specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
